Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Enrico Vanni
AddedFeb 20, 2024
UpdatedMay 31, 2026
Enrico Vanni

Enrico Vanni

Board Member, Novartis

Crunchbase

Enrico Vanni's Career

Novartis
Novartis

Basel, Basel-Stadt, CH

Board Member· Board
Lombard Odier & Cie
Lombard Odier & Cie

Geneva, Canton of Geneva, CH

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Enrico Vanni's Career

Novartis
Novartis
Public$6.5M101.7k2002Basel, Basel-Stadt, CH
Board Member· Board

Leadership at Novartis

Nancy AndrewsNancy AndrewsBoard Member
Srikant DatarSrikant DatarBoard Member
Ann Marie FudgeAnn Marie FudgeBoard Member
Joerg ReinhardtJoerg ReinhardtBoard Member
Vasant NarasimhanVasant NarasimhanCEO
Andreas Von PlantaAndreas Von PlantaBoard Member

Similar to Novartis

Novartis Institutes For Biomedical ResearchNovartis Institutes For Biomedical ResearchCambridge, MA, USDrug Discoveryest. 2002Novartis Institutes For Biomedical ResearchCambridge, MA, US · est. 2002

Novartis Institutes For Biomedical Research: A noncommercial research organization founded in 2002.

10k
Novartis PharmaNovartis PharmaTokyo, Tokyo, JPPharmaceuticalsest. 1997Novartis PharmaTokyo, Tokyo, JP · est. 1997

Tokyo-based Novartis Pharma, a key subsidiary of global healthcare leader Novartis Pharmaceuticals.

Public3k
Bristol Myers SquibbBristol Myers SquibbNew York City, NY, USPharmaceuticalsest. 1887Bristol Myers SquibbNew York City, NY, US · est. 1887

Leading American pharmaceutical company specializing in research and development.

Public · $10.6B34.3k
LonzaLonzaBasel, Basel-Stadt, CHBiotech, Pharmaceuticalsest. 1897LonzaBasel, Basel-Stadt, CH · est. 1897

Swiss-based Lonza, a global partner in pharmaceuticals, biotech, and nutrition, develops and commercializes medical treatments worldwide.

Public · $400M17.5k
Lombard Odier & Cie
Lombard Odier & Cie
Investment FirmInvestment Firm2.7k1796Geneva, Canton of Geneva, CH
Board Member· Board

Leadership at Lombard Odier & Cie

Henri HentschHenri HentschFounder
Susie BeeSusie BeeCEO
PATRICK ODIERPATRICK ODIERBoard Member
Dr Henry Martin PeterDr Henry Martin PeterBoard Member
Thierry LombardThierry LombardBoard Member

Similar to Lombard Odier & Cie

UBSUBSZürich, Zürich, CHest. 1862UBSZürich, Zürich, CH · est. 1862

UBS Group AG: A Swiss-based global investment bank and financial services firm, renowned for banking secrecy.

Investment Firm · $4.8B74k
Pictet GroupPictet GroupGeneva, Canton of Geneva, CHest. 1805Pictet GroupGeneva, Canton of Geneva, CH · est. 1805

Pictet Group: A leading Swiss private bank offering wealth and asset management services.

Investment Firm1.1k
Julius BaerJulius BaerZürich, Zürich, CHest. 1890Julius BaerZürich, Zürich, CH · est. 1890

Swiss-based Julius Baer & Co. AG provides private banking, wealth management, and investment advisory services globally.

Investment Firm6.9k
VontobelVontobelBasel, Basel-Stadt, CHest. 1924VontobelBasel, Basel-Stadt, CH · est. 1924

Swiss-based Vontobel Holding AG offers premier private banking and investment management services.

Investment Firm2.5k

Enrico Vanni's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Enrico Vanni

Laurent ChaixLaurent ChaixBoard Member · Sectoral Asset ManagementMirko BianchiMirko BianchiBoard Member · Credit Suisse First BostonChristian MeissnerChristian MeissnerBoard Member · Credit Suisse First BostonWINNIE PAOWINNIE PAOBoard Member · Sectoral Asset ManagementJasper TansJasper TansBoard Member · UBS Investment Bank